Navigation

Macular oedema (retinal vein occlusion) - dexamethasone

Dexamethasone intravitreal implant for the treatment of macular oedema caused by retinal vein occlusion (RVO)

Status: History
Expected date of issue: July 2011
Referral date: June 2010
Process: STA
Notes:

Scoped within Batch 11

Topic area:
  • Eye
 

NICE project team

Executive Lead: Andrew Dillon
Technical Lead: Jennifer Priaulx
Communications manager: Shalu Kanal
Project manager: Lori Farrar
Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: 27 Sept 2010
1st appraisal committee meeting: 11 January 2011
Top


 

Consultees and commentators

Consultees

 

Commentators (no right to submit or appeal)

 

Manufacturers/sponsors

  • Allergan Pharmaceuticals Ireland (dexamethasone)

Patient/carer groups

  • Royal National Institute of Blind People (RNIB)

Professional groups

  • Royal College of Nursing
  • Royal College of Ophthalmologists
  • Royal College of Physicians

Others

  • Department of Health
  • Welsh Assembly Government

General

  • British National Formulary
  • Commissioning Support Appraisals Service
  • Department of Health, Social Services and Public Safety for Northern Ireland
  • NHS Quality Improvement Scotland

Possible comparator manufacturers

  • Bristol Myers Squibb (triamcinolone)
  • Roche Products (bevacizumab)

Relevant research groups

  • None

Evidence Review Group

  • Aberdeen HTA Group
  • National Institute for Health Research Health Technology Assessment Programme

Associated Guideline Groups

  • None

Associated Public Health Groups

  • None

Top


 

Key documents

This page was last updated: 27 July 2011

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.